Skip to content
Unrated Drug recall · FDA · Published April 20, 2026

Scope Health Optase Dry Eye Drops Recall: Lack of Sterility Assurance

Scope Health recalls Optase Dry Eye Intense Drops (Glycerin 0.2%) due to lack of sterility assurance. Products with specific lot numbers and expiration dates are affected. Consumers should check their product details and contact Scope Health for guidance.

🇺🇸 FDA recall #D-0499-2026DrugScope Health ›
Take action

Contact the company

Recalling firmSCOPE HEALTH79 Madison Avenue, 27 E 28th St · New York, NY 10016-7921
✎ GovInfoNow plain-language explainer

Scope Health is recalling Optase Dry Eye Intense Drops (Glycerin 0.2%) because they may not be sterile. This could lead to infections if used improperly. The recall affects specific lot numbers and expiration dates. Read more at govinfonow.com/recall/31345-scope-health-optase-dry-eye-drops-recall-lack-of-sterility.

Source Summary by GovInfoNow · govinfonow.com/recall/31345-scope-health-optase-dry-eye-drops-recall-lack-of-sterility · Updated August 17, 2026 · FDA enforcement record: FDA #D-0499-2026

Cite this page

“Scope Health Optase Dry Eye Drops Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31345-scope-health-optase-dry-eye-drops-recall-lack-of-sterility. Based on FDA recall #D-0499-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0499-2026%22&limit=1).

The FDA announced on April 20, 2026, that Scope Health is recalling Optase Dry Eye Intense Drops due to a lack of sterility assurance. The agency issued recall number D-0499-2026 for the Class II voluntary recall.

How to tell if you have it

  • Brand: Scope Health
  • Product: Optase Dry Eye Intense Drops (Glycerin 0.2%)
  • Size: 0.33 fl oz
  • NDC: 72972-002-01
  • Lot codes: 8T98, 9T31, 9T32 (Exp. 30/04/26); 2V13, 2V14, 2V15 (Exp. 30/06/26); 3V35 (Exp. 31/08/26); 3V36, 3V37 (Exp. 30/09/26); 5V45, 5V46, 9V12 (Exp. 31/03/27); 1X57, 1X70, 1X84 (Exp. 31/05/27)
  • Distribution: Nationwide within the United States

The hazard

The product lacks assurance of sterility. According to FDA's FAERS database, there are 2,595 adverse-event reports naming this product, with 2,403 marked serious and 365 listing a death, though these are unverified reports not findings about this recall.

Context

GovInfoNow's records show other recent recalls of similar products include K.C. Pharmaceuticals Dry Eye Relief Eye Drops Recall (2026-03-03) and Clear Eyes Eye Drops Recalled for Sterility Risk (2026-07-29). Additional related actions include the Clear Eyes Eye Drops Recall: Lack of Sterility Risk reported on 2026-09-15.

How to tell if you have this one

Check the product label for the lot numbers: 8T98, 9T31, 9T32, 2V13, 2V14, 2V15, 3V35, 3V36, 3V37, 5V45, 5V46, 9V12, 1X57, 1X70, 1X84. Also look for the expiration dates listed: 30/04/26, 30/06/26, 31/08/26, 30/09/26, 31/03/27, 31/05/27.

  • Brand
    Scope Health
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot numbers and expiration dates on the product label to confirm if it is recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 16 days after the firm started it.

1. Firm started the recall: Apr 20, 202612. FDA classified it Class II: Apr 28, 202623. Published in FDA’s Enforcement Report: May 6, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0499-2026 (April 20, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0499-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA